Skip to content
Clinical Trials – home
PortugalBack to Portugal

Clinical trials in Portimao

18 clinical trials in Portimao, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.

PortugalOur site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Portimao at a glance
18
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

18 trials in Portimao

Open in trial search
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen - Cilag International

Crohn's disease

Recruiting
Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Eli Lilly & Co.
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen - Cilag International
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:Janssen - Cilag International
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Bicara Therapeutics Inc.
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:Takeda Development Center Americas Inc.
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:LETI Pharma S.L.U.

Crohn's disease

Not recruiting
Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen - Cilag International

Crohn's disease

Not recruiting
Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Genmab A/S
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Genmab A/S

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Portimao

What the registry says about research in the country

01 Nephrology Research

Clinical trials focusing on end-stage kidney disease and its complications, particularly investigating new treatments for patients undergoing hemodialysis.

  • Secondary Hyperparathyroidism Management
  • Arteriovenous Graft Thrombosis Prevention
  • Hemodialysis Complications

Studies aim to improve outcomes for dialysis patients through innovative therapeutic approaches.

02 Inflammatory Bowel Disease Studies

Comprehensive research into treatments for ulcerative colitis, evaluating both established and novel therapeutic approaches.

  • Risankizumab Efficacy Trials
  • Combination Therapy Assessment
  • Long-term Safety Studies

Investigations focus on maintaining disease remission and improving quality of life.

03 Crohn's Disease Research

Advanced clinical trials examining innovative treatments for moderately to severely active Crohn's disease.

  • Guselkumab Therapeutic Studies
  • Combination Treatment Protocols
  • Maintenance Therapy Evaluation

Research aims to establish more effective treatment options for long-term disease management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.